June 2023 ACIP Meeting - RSV Vaccines - Adult

Introduction; Manufacturer presentation: Pfizer season 2 safety & efficacy; coadministration with influenza vaccine, Manufacturer presentation: GSK season 2 safety & efficacy; coadministration with influenza vaccine, Updated cost-effectiveness of the Pfizer and GSK vaccines (main CDC model), Comparison of cost effectiveness results of the main CDC model and each manufacturer model (Pfizer & GSK), Updated EtR (incl. GRADE) and clinical considerations for 2 vaccines (Pfizer & GSK)
This video can also be viewed at
www.cdc.gov/va...